Handelsinvest Investeringsforvaltning Abb Vie Inc. Transaction History

Handelsinvest Investeringsforvaltning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 11, 2019	SELL	$77.14 - $90.79 $538,822 - $634,168	-6,985 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $119,888 - $147,855	1,540 Added 28.28%	6,985 $644,000
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $250,127 - $295,956	-2,786 Reduced 33.85%	5,445 $504,000
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $202,422 - $271,062	-2,200 Reduced 21.09%	8,231 $779,000
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $728,605 - $930,653	10,431	10,431 $927,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.